Research Methodology – Clinical Trial Imaging Market
At Straits Research, we adopt a rigorous 360° research approach that integrates both primary and secondary research methodologies. This ensures accuracy, reliability, and actionable insights for stakeholders. Our methodology for the Clinical Trial Imaging Market comprises the following key stages:
Market Indicator & Macro-Factor Analysis
Our baseline thesis for the Clinical Trial Imaging Market is developed by integrating key market indicators and macroeconomic variables. These include:
1 Factors considered while calculating market size and share
- The overall number of clinical trials conducted globally and specifically focusing on imaging.
- The growth rate of clinical trials in recent years.
- Advancements in medical imaging technology.
- The number of pathology labs and diagnostic centers globally.
- Investments in medical imaging-related technologies.
- The level of competition within the clinical trial imaging market.
- The spending capacity of end-users (i.e., hospitals, labs, research centers) on clinical trial imaging solutions.
- Regulatory policies and its impacts on the market.
2 Key Market Indicators
- The growth rate of clinical trials.
- New medical imaging technologies coming into the market.
- The rate of adoption of these technologies in clinical trials.
- Increase or decrease in healthcare spending on clinical research and trials.
- Healthcare infrastructure expansion globally.
- The number of patents registered in the field of medical imaging.
- Regulatory approvals and disapprovals of imaging devices used in clinical trials.
3 Growth Trends
- Increase in partnerships and collaborations between tech companies and healthcare institutions for advancement in clinical trial imaging.
- The rising trend of artificial intelligence and machine learning in clinical trial imaging.
- Growing focus on personalized medicine boosting demand for more specific clinical trial imaging.
- Increased investment in R&D in the healthcare sector.
- Rising prevalence of chronic diseases leading to more demand for clinical trials and consequently clinical trial imaging.
- The shift towards more virtual and decentralized trials post-COVID-19 pandemic, augmenting demand for advanced imaging techniques.
Secondary Research
Our secondary research forms the foundation of market understanding and scope definition. We collect and analyze information from multiple reliable sources to map the overall ecosystem of the Clinical Trial Imaging Market. Key inputs include:
- Annual reports, investor presentations, SEC filings
- Company press releases and product launch announcements
- Public executive interviews and earnings calls
- Strategy briefings and M&A updates
- Country-level industry associations and trade bodies
- Government dossiers, policy frameworks, and official releases
- Whitepapers, working papers, and public R&D initiatives
- Relevant Associations for the Clinical Trial Imaging Market
- Broker reports and financial analyst coverage
- Paid databases (Hoovers, Factiva, Refinitiv, Reuters, Statista, etc.)
- Import/export trade data and tariff databases
- Sector-specific journals, magazines, and news portals
- Global macroeconomic indicators and their cascading effect on the industry
- Demand–supply outlook and value chain analysis
- Consumer behaviour, adoption rates, and commercialization trends
Primary Research
To validate and enrich our secondary findings, we conduct extensive primary research with industry stakeholders across the value chain. This ensures we capture both qualitative insights and quantitative validation. Our primary research includes:
- Key Opinion Leader (KOL) Engagements
- Structured interviews with executives, product managers, and domain experts
- Paid and barter-based interviews across manufacturers, distributors, and end-users
- Discussions with stakeholders to validate demand-supply gaps
- Group discussions on emerging technologies, regulatory shifts, and adoption barriers
- Cross-verification of market sizing and forecasts with industry insiders
- Capturing business perspectives on growth opportunities and restraints
Data Triangulation & Forecasting
The final step of our research involves data triangulation ensuring accuracy through cross-verification of:
- Demand-side analysis (consumption patterns, adoption trends, customer spending)
- Supply-side analysis (production, capacity, distribution, and market availability)
- Macroeconomic & microeconomic impact factors
- Time-series analysis
- Regression and correlation studies
- Baseline modeling
- Expert validation at each stage
Outcome
The outcome is a comprehensive and validated market model that captures:
- Market sizing (historical, current, forecast)
- Growth drivers and restraints
- Opportunity mapping and investment hotspots
- Competitive positioning and strategic insights
Available for purchase with detailed segment data, forecasts, and regional insights.
Get This ReportOur Clients:
